HBM Healthcare Investments Concludes Share Buyback Programme

HBM Healthcare Investments AG completed its 2022 share buyback programme on 27 June 2025. The initiative, which began in June 2022, saw the company repurchase a total of 252,610 shares. These transactions occurred via a separate trading line on the SIX Swiss Exchange at an aggregate cost of CHF 46.3 million. The purchased shares are designated for cancellation through a capital reduction, aiming to enhance shareholder value.

The buyback reflects HBM Healthcare's ongoing efforts to manage its capital structure effectively. Through strategic share repurchases, the company reinforces its commitment to delivering value to shareholders. The completion of the programme marks a significant milestone in HBM Healthcare's financial strategy.